MATE-1 modulation by kinin B1 receptor enhances cisplatin efflux from renal cells

被引:0
作者
Gabriel R. Estrela
Frederick Wasinski
Raphael J. F. Felizardo
Laura L. Souza
Niels O. S. Câmara
Michael Bader
Ronaldo C. Araujo
机构
[1] Federal University of São Paulo,Department of Biophysics
[2] Federal University of São Paulo,Department of Medicine, Division of Nephrology
[3] University of São Paulo,Department of Immunology, Laboratory of Transplantation Immunobiology, Institute of Biomedical Sciences
[4] Max Delbrück Center for Molecular Medicine,undefined
来源
Molecular and Cellular Biochemistry | 2017年 / 428卷
关键词
Cisplatin nephrotoxicity; Organic transporters; Kinins;
D O I
暂无
中图分类号
学科分类号
摘要
Cisplatin is a drug widely used in chemotherapy that frequently causes severe renal dysfunction. Organic transporters have an important role to control the absorption and excretion of cisplatin in renal cells. Deletion and blockage of kinin B1 receptor has already been show to protect against cisplatin-induced acute kidney injury. To test whether it exerts its protective function by modulating the organic transporters in kidney, we studied kinin B1 receptor knockout mice and treatment with a receptor antagonist at basal state and in presence of cisplatin. Cisplatin administration caused downregulation of renal organic transporters; in B1 receptor knockout mice, this downregulation of organic transporters in kidney was absent; and treatment by a B1 receptor antagonist attenuated the downregulation of the transporter MATE-1. Moreover, kinin B1 receptor deletion and blockage at basal state resulted in higher renal expression of MATE-1. Moreover we observed that kinin B1 receptor deletion and blockage result in less accumulation of platinum in renal tissue. Thus, we propose that B1 receptor deletion and blockage protect the kidney from cisplatin-induced acute kidney injury by upregulating the expression of MATE-1, thereby increasing the efflux of cisplatin from renal cells.
引用
收藏
页码:101 / 108
页数:7
相关论文
共 160 条
  • [1] Arany I(2003)Cisplatin nephrotoxicity Semin Nephrol 23 460-464
  • [2] Safirstein RL(2010)Mechanisms of Cisplatin nephrotoxicity Toxins (Basel) 2 2490-2518
  • [3] Miller RP(1996)Acute renal failure N Engl J Med 334 1448-1460
  • [4] Tadagavadi RK(2008)Regulation of renal organic ion transporters in cisplatin-induced acute kidney injury and uremia in rats Pharm Res 25 2526-2533
  • [5] Ramesh G(2007)Cisplatin nephrotoxicity: a review Am J Med Sci 334 115-124
  • [6] Reeves WB(2013)Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney Aaps J 15 581-588
  • [7] Thadhani R(2013)Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease Aaps J 15 53-69
  • [8] Pascual M(2008)Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury Drug Metab Dispos 36 649-654
  • [9] Bonventre JV(2012)Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients Clin Cancer Res 18 1101-1108
  • [10] Morisaki T(2004)Nephrotoxicity of platinum complexes is related to basolateral organic cation transport Kidney Int 66 196-202